Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
CN |
|
A
|
Airbus SE
MIL:AIR
|
NL |
|
Synopsys Inc
NASDAQ:SNPS
|
US |
|
Fubon Financial Holding Co Ltd
OTC:FUIZF
|
TW |
|
A
|
Adecco Group AG
F:ADI1
|
CH |
|
A
|
Antofagasta PLC
OTC:ANFGF
|
UK |
|
Diamondback Energy Inc
NASDAQ:FANG
|
US |
|
S
|
Southern Copper Corp
DUS:PCU
|
US |
|
L
|
Leonardo SpA
XHAM:FMNB
|
IT |
|
Fortuna Silver Mines Inc
TSX:FVI
|
CA |
|
M
|
Magna International Inc
SWB:MGA
|
CA |
|
B
|
Booking Holdings Inc
XBER:PCE1
|
US |
|
B
|
Bank of America Corp
XETRA:NCB
|
US |
|
Electrocomponents PLC
OTC:EENEF
|
UK |
|
B
|
Booking Holdings Inc
XMUN:PCE1
|
US |
|
S
|
Sicily By Car SpA
F:5LC
|
IT |
|
N
|
Naver Corp
OTC:NHNCF
|
KR |
|
B
|
BHP Group Ltd
F:BHP1
|
AU |
|
S
|
Stericycle Inc
DUS:SY9
|
US |
|
Swiss Prime Site AG
SIX:SPSN
|
CH |
|
M
|
Mobico Group PLC
XMUN:3NA
|
UK |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
|
W
|
Wolters Kluwer NV
SWB:WOSB
|
NL |
|
C
|
CITIC Ltd
F:CPF
|
CN |
Wall St Price Targets
Price Targets Summary
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is 575.69 HKD with a low forecast of 505.71 HKD and a high forecast of 700.35 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's stock price target?
Price Target
575.69
HKD
According to Wall Street analysts, the average 1-year price target for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is 575.69 HKD with a low forecast of 505.71 HKD and a high forecast of 700.35 HKD.
What is the Revenue forecast for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?
Projected CAGR
35%
Over the last 3 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 35%.
What is the Gross Profit forecast for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?
Projected CAGR
38%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 8 years is 38%.
